Cargando…

Do inhibitors of the renin–angiotensin system prevent chronic kidney disease?

Detalles Bibliográficos
Autor principal:	Rayner, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Clinics Cardive Publishing 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721257/ https://www.ncbi.nlm.nih.gov/pubmed/20224837

Ejemplares similares

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Inhibition of the renin-angiotensin system during fetal kidney development
por: Park, Eujin
Publicado: (2020)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
por: Singhania, Namrata, et al.
Publicado: (2020)

The Yin and Yang of the Renin–Angiotensin–Aldosterone System in Acute Kidney Injury
por: Legrand, Matthieu, et al.
Publicado: (2021)

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
por: Miyazaki, Hiroki, et al.
Publicado: (2015)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
por: Silva-Cardoso, José, et al.
Publicado: (2022)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Medication use, renin–angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney disease
por: Neumiller, Joshua J, et al.
Publicado: (2020)

Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Effect of Discontinuation of Renin Angiotensin-System Inhibitors in Patients With Advanced Chronic Kidney Disease: A Meta-Analysis
por: Naveed, Husnain, et al.
Publicado: (2023)

Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis
por: Tang, Chen, et al.
Publicado: (2023)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
por: Loader, Jordan, et al.
Publicado: (2021)

Targeting the Renin–Angiotensin–Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Renin-Angiotensin System Inhibitors in Advanced CKD: a #NephJC Editorial on STOP-ACEi
por: Thanabalasingam, Susan, et al.
Publicado: (2023)

Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
por: Park, Jae-Hyeong
Publicado: (2023)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes
por: Gnudi, Luigi, et al.
Publicado: (2010)

Characterization of the intrarenal renin‐angiotensin system in cats with naturally occurring chronic kidney disease
por: Lourenço, Bianca N., et al.
Publicado: (2022)

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
por: Huang, Rong-Shuang, et al.
Publicado: (2016)

Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
por: Weinstein, Jordan, et al.
Publicado: (2021)

The role of renin angiotensin system inhibition in kidney repair
por: van der Meer, Irene M, et al.
Publicado: (2010)

Chronic effects of lead on the renin-angiotensin system.
por: Vander, A J
Publicado: (1988)

Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney
por: Jang, In-Ae, et al.
Publicado: (2018)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
por: Komers, Radko, et al.
Publicado: (2016)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
por: Miller, Matthew, et al.
Publicado: (2022)

Cognitive decline: mechanisms and proposed role of the renin–angiotensin–aldosterone system
por: Opie, Lionel H
Publicado: (2014)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation
por: Chappell, Mark C
Publicado: (2010)

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease
por: Saigusa, Takamitsu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v76t8n5j9l2loof4p74m2bpflj